CONMED Corporation to Present at the J.P. Morgan Healthcare Conference
21 December 2018 - 8:01AM
Business Wire
CONMED Corporation (NASDAQ: CNMD) today announced that
Curt R. Hartman, President and Chief Executive Officer, and Todd W.
Garner, Executive Vice President and Chief Financial Officer, will
present at the 37th Annual J.P. Morgan Healthcare Conference at
4:30 p.m. PT on Wednesday, January 9, 2019 in San Francisco,
CA.
A live webcast of the presentation and Q&A breakout session
will be accessible through the “Investors” section of the Company’s
website at www.conmed.com and will be available for replay
following the event.
About CONMED Corporation
CONMED is a medical technology company that provides surgical
devices and equipment for minimally invasive procedures. The
Company’s products are used by surgeons and physicians in a variety
of specialties, including orthopedics, general surgery, gynecology,
neurosurgery and gastroenterology. CONMED has a direct selling
presence in 19 countries, and international sales constitute
approximately 50% of the Company’s total sales. Headquartered in
Utica, New York, the Company employs approximately 3,100 people.
For more information, visit www.conmed.com.
Forward-Looking Statements
This press release may contain forward-looking statements based
on certain assumptions and contingencies that involve risks and
uncertainties, which could cause actual results, performance, or
trends to differ materially from those expressed in the
forward-looking statements herein or in previous disclosures. For
example, in addition to general industry and economic conditions,
factors that could cause actual results to differ materially from
those in the forward-looking statements may include, but are not
limited to, the risk factors discussed in the Company's Annual
Report on Form 10-K for the fiscal year ended December 31, 2017,
and listed under the heading Forward-Looking Statements in the
Company’s most recently filed Form 10-Q. Any and all
forward-looking statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995
and relate to the Company’s performance on a going-forward basis.
The Company believes that all forward-looking statements made by it
have a reasonable basis, but there can be no assurance that
management’s expectations, beliefs or projections as expressed in
the forward-looking statements will actually occur or prove to be
correct.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20181220005667/en/
CONMED CorporationTodd W. GarnerChief Financial
Officer315-624-3317ToddGarner@conmed.com
CONMED (NASDAQ:CNMD)
Historical Stock Chart
From Sep 2024 to Oct 2024
CONMED (NASDAQ:CNMD)
Historical Stock Chart
From Oct 2023 to Oct 2024